Allergan's Back In The (M&A) Saddle Again Post-Pfizer Breakup
This article was originally published in The Pink Sheet Daily
Executive Summary
CEO Brent Saunders says company now is "recharged" and "ready to go," and it ends the day announcing a partnership wth Heptares.